Loading the player… Velvet Brown-Watts, MSW-ADM, CM., and Jeremiah Watts are at the forefront of raising awareness on sickle cell in their Oklahoma community and providing resources to those impacted by the disease. The couple is not only advocates but knows what it’s like firsthand to be supportive of someone living with the disease. Their… Read More »
May 1, 2021 Approval is based on demonstrated reduction in liver iron concentration Expanded indications for patients with sickle cell disease or other anemias, as well as thalassemia – BOSTON, May 1, 2021 /PRNewswire/ — Chiesi Global Rare Diseases, a business unit of Chiesi Farmaceutici S.p.A., an international research-focused healthcare Group (Chiesi Group), announced today… Read More »
Fitness fanatic Barry Newman’s weak heart had him fearing for his life before fate stepped in with a revolutionary medical procedure – and an old girlfriend. He was a shell of his former self, his heart at just 13% of its normal capacity, and a transplant looked like the only viable solution. By chance, one… Read More »
Researchers at Trinity College Dublin have identified a so-called “executioner cell” that may hold the key to eventually finding a treatment to slow retinal degeneration that causes blindness in millions of people each year. A multi-disciplinary team involving experts from TCD believe they have pinpointed a potential new therapeutic target for treating retinal degeneration. It… Read More »
How to Clean Your Cell Phone—And How Often You Should | Reader’s Digest Skip links Reader's Digest
By Clare Wilson People with organ transplants currently have to take drugs to stop the donor organ being rejectedCraig Stennett/Alamy A one-off injection of cells could be a long-sought solution to the problem of the body rejecting an organ transplant. The first person who may have benefited from this approach is an Italian man who… Read More »
Print this page South San Francisco, CA — December 3, 2019 — Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) approved Tecentriq (atezolizumab) in combination with chemotherapy (Abraxane ® [paclitaxel protein-bound; nab-paclitaxel] and carboplatin) for the initial (first-line) treatment of adults… Read More »